DOCSLIB.ORG

Hippo Signaling, a Critical Tumor Suppressor Ana Sebio1,2 and Heinz-Josef Lenz2,3,4

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Hippo Signaling, a Critical Tumor Suppressor Ana Sebio1,2 and Heinz-Josef Lenz2,3,4 Published OnlineFirst September 17, 2015; DOI: 10.1158/1078-0432.CCR-15-0411 Molecular Pathways Clinical Cancer Research Molecular Pathways: Hippo Signaling, a Critical Tumor Suppressor Ana Sebio1,2 and Heinz-Josef Lenz2,3,4 Abstract The Salvador–Warts–Hippo pathway controls cell fate and linked to some of the most important signaling pathways tissue growth. The main function of the Hippo pathway is to involved in cancer development and progression. A better prevent YAP and TAZ translocation to the nucleus where they understanding of the Hippo pathway is thus essential to untan- induce the transcription of genes involved in cell proliferation, gle tumor biology and to develop novel anticancer therapies. survival, and stem cell maintenance. Hippo signaling is, thus, a Here, we comment on the progress made in understanding complex tumor suppressor, and its deregulation is a key feature in Hipposignalinganditsconnections,andalsoonhownew many cancers. Recent mounting evidence suggests that the over- drugs modulating this pathway, such as VerteporfinandC19, expression of Hippo components can be useful prognostic bio- are highly promising cancer therapeutics. Clin Cancer Res; 21(22); markers. Moreover, Hippo signaling appears to be intimately 5002–7. Ó2015 AACR. Background way is inactive or suppressed, YAP and TAZ translocate to the nucleus. In the nucleus, they regulate the activity of various The Salvador–Warts–Hippo pathway (known as Hippo path- transcription factors involved in cell proliferation, survival, way) was first discovered to be involved in controlling tissue microRNA processing, metastases development, and stem cell growth in Drosophila melanogaster in 2002, and it has recently maintenance such as SMADs, TEADs, TBX5, and RUNT1,2 and emerged as a critical tumor-suppressor network (1). The Hippo p73 (2–4). On the basis of this action mechanism, Hippo pathway is a highly evolutionarily conserved pathway that effectors YAP and TAZ can act either as tumor suppressors controls multiple functions that are crucial to several carcino- when located in the cytoplasm or as oncogenes by facilitating genesis processes such as proliferation, apoptosis, and stem cell transcriptional activationinthenucleus(Fig.1). maintenance. Hippo controls cell proliferation and survival mainly by The core of the mammalian Hippo pathway consists of a sensing the physical state of cells within a tissue through several protein complex that includes kinases MST1 and MST2 (also mechanisms. Unlike other pathways, Hippo does not have known as STK4 and STK3), large tumor suppressors 1 and 2 dedicated extracellular ligand–receptor complexes. Instead, the (LATS1 and LATS2) and adaptor proteins SAV1 (Salvador upstream signaling of Hippo involves many mechanisms and homolog 1) and MOB kinase activator 1A and 1B (MOB1A other signaling pathways. These upstream inputs can be divid- and MOB1B). MST1 and MST2 facilitate LATS1 and LATS2 ed into those controlling the pathway by retaining YAP/TAZ in phosphorylation, which in turn facilitates LATS-dependent the cytoplasm by physical interaction, and those that activate phosphorylation of the homologous oncoproteins YAP (Yes- the core kinase complex MST/LATS leading to YAP/TAZ phos- associated protein; encoded by YAP1) and TAZ (PDZ-binding phorylation. Some of the most relevant upstream regulators of motif, also known as WWTR1). When the Hippo pathway is Hippo include the following: (i) FERM domain–containing active, its main effectors, YAP and TAZ, are phosphorylated by proteins NF2 and KIBRA and WILLIN (5), (ii) polarization the Hippo core complex and retained in the cytoplasm where and adhesion proteins, including those controlling basolateral they undergo proteasomal degradation. When the Hippo path- polarity like the SCRIBBLE complex (6), apical polarity like the CRUMBS complex (7), and planar cell polarity like the FAT and 1 Dachsous family of cadherins (8). Cell adhesion proteins, such Medical Oncology Department, Santa Creu I Sant Pau Hospital, Uni- a versitat Autonoma de Barcelona, Barcelona, Spain. 2Sharon A. Car- as -catenin and E-cadherin (9), (iii) extracellular factors, G penter Laboratory, Norris Comprehensive Cancer Center, Keck School protein–coupled receptors (GPCR) and tyrosine kinase inhib- of Medicine, University of Southern California, Los Angeles, California. itor (TKI) receptors, and (iv) changes in mechanical forces 3Division of Medical Oncology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los regulated by Rho and F-actin polymerization that can also Angeles, California. 4Department of Preventive Medicine, Norris Com- regulate YAP/TAZ nuclear localization (10). prehensive Cancer Center, Keck School of Medicine, University of Other proteins can also directly affect TAZ and YAP. These Southern California, Los Angeles, California. include WBP2, MASK proteins, HIPK2 and 14-3-3 proteins. Corresponding Author: Heinz-Josef Lenz, Norris Comprehensive Cancer Cen- Moreover, other proteins can interact with the upstream kinase ter, University of Southern California, 1441 Eastlake Avenue, Los Angeles, CA complex. Of particular interest is Rassf1, a tumor-suppressor 90033. Phone: 323-865-3967; Fax: 323-865-0061; E-mail: [email protected] frequently methylated in several tumors, which can act as a Hippo doi: 10.1158/1078-0432.CCR-15-0411 regulator. Rassf1a can bind MST regulating LATS1/2 phosphor- Ó2015 American Association for Cancer Research. ylation and promoting proapoptotic signals through p73. 5002 Clin Cancer Res; 21(22) November 15, 2015 Downloaded from clincancerres.aacrjournals.org on September 27, 2021. © 2015 American Association for Cancer Research. Published OnlineFirst September 17, 2015; DOI: 10.1158/1078-0432.CCR-15-0411 Hippo as a Tumor Suppressor FAT Cytoplasm G-protein coupled WILLIN KIBRA NF2 receptors Gα Junctions other Adrenaline, Rassf1a YAP MST1/2 TAZ glucagon, Gαs P E-cadherin dihydrexidine SAV1 α-catenin C19 MOB1 P Dobutamin β-adrenergic LATS1/2 YAP P CRUMBS complex TAZ P P YAP YAP YAP YAP 14-3-3 TAZ TAZ TAZ SCRIBBLE complex YAP/TAZ TAZ Botulinum proteosomal toxin C3, degradation Y27632, Nucleus simvastatin YAP YAP F-actin TAZ TAZ Verteporfin, VGLL4- mimicking peptide Rho SMAD 1–4 TEAD mRNA processing YAP AREG, Axin2, TAZ TCF p73 Hippo target genes Sox2, CTGF, Cyr61, Cytochalasin β-catenin Birc5, Id1, Id2, Mechanical D, latrunculin Pai-1, SMAD7, Myc stress A and B, Blebbistain Dasatinib © 2015 American Association for Cancer Research Figure 1. The Hippo signaling pathway and main regulators. The core of Hippo signaling consists of a group of kinases (MST1/2 and LATS1/2) and adaptor proteins SAV1 and MOB1, which by phosphorylating the Hippo pathway effectors YAP and TAZ, retain them in the cytoplasm. In the cytoplasm, YAP/TAZ undergo proteosomal degradation. YAP and TAZ, if not retained in the cytoplasm, can translocate to the nucleus where they regulate the activity of several transcription factors that induce the expression of Hippo target genes involved in cancer development and progression. Upstream regulation of Hippo includes: (i) FERM domain– containing proteins (NF2 KIBRA and WILLIN) that activate the core kinase complex, (ii) polarization and adhesion proteins like a-catenin, E-cadherin, CRUMBS, and SCRIBBLE complexes that can sequester YAP/TAZ in the cytoplasm, (iii) GPCRs that can be divided in those signaling through GaS leading to activation of Hippo cascade or those signaling through other Ga subunits that favor YAP/TAZ nuclear translocation, and (iv) Mechanical stress regulated by F-actin can also increase YAP/TAZ cytoplasmic location. In addition, independent proteins like Rassf1a and several pathways regulate Hippo signaling. New molecules and drugs under development to modulate Hippo signaling are represented in yellow. For more detailed information on Hippo upstream regulators schwanomas (13). In addition, mutations and deletions in LATS2 and downstream effectors, we refer the reader to some of the can be frequently found in malignant mesothelioma (14). In excellent reviews previously published (8, 11). mice, mutations in Hippo components lead to developmental deficiencies within the intestinal epithelium, liver, or skin kera- – – – tinocytes (15 17). Although YAP/TAZ activating mutations have Clinical Translational Advances not been described, high YAP/TAZ nuclear levels are present in Disruptions in the correct function of this pathway have been several cancer types (18). High YAP/TAZ nuclear levels favor cell found to take part in several tumorigenesis mechanisms. How- proliferation and survival as well as the acquisition of a cancer- ever, in human cancer, mutations in the Hippo components are promoting phenotype. Stem cell maintenance is intimately linked infrequent (12). The most established mutation is located in the to Hippo signaling in tumor cells. In breast tumors, in vitro studies tumor-suppressor NF2, an upstream Hippo regulator, causing the show how TAZ acts as a stem cell promoter, providing stem cells autosomal dominant syndrome type 2 neurofibromatosis that with self-renewal and tumor-initiating capacity. This property is entails, among others the development of meningiomas and acquired in part by forming a complex with the polarity complex www.aacrjournals.org Clin Cancer Res; 21(22) November 15, 2015 5003 Downloaded from clincancerres.aacrjournals.org on September 27, 2021. © 2015 American Association for Cancer Research. Published OnlineFirst September 17, 2015; DOI: 10.1158/1078-0432.CCR-15-0411
Load more

Recommended publications
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • The Legionella Kinase Legk7 Exploits the Hippo Pathway Scaffold Protein MOB1A for Allostery and Substrate Phosphorylation
    The Legionella kinase LegK7 exploits the Hippo pathway scaffold protein MOB1A for allostery and substrate phosphorylation Pei-Chung Leea,b,1, Ksenia Beyrakhovac,1, Caishuang Xuc, Michal T. Bonieckic, Mitchell H. Leea, Chisom J. Onub, Andrey M. Grishinc, Matthias P. Machnera,2, and Miroslaw Cyglerc,2 aDivision of Molecular and Cellular Biology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, Bethesda, MD 20892; bDepartment of Biological Sciences, College of Liberal Arts and Sciences, Wayne State University, Detroit, MI 48202; and cDepartment of Biochemistry, University of Saskatchewan, Saskatoon, SK S7N5E5, Canada Edited by Ralph R. Isberg, Tufts University School of Medicine, Boston, MA, and approved May 1, 2020 (received for review January 12, 2020) During infection, the bacterial pathogen Legionella pneumophila Active LATS1/2 phosphorylate the cotranscriptional regulator manipulates a variety of host cell signaling pathways, including YAP1 (yes-associated protein 1) and its homolog TAZ (tran- the Hippo pathway which controls cell proliferation and differen- scriptional coactivator with PDZ-binding motif). Phosphorylated tiation in eukaryotes. Our previous studies revealed that L. pneu- YAP1 and TAZ are prevented from entering the nucleus by being mophila encodes the effector kinase LegK7 which phosphorylates either sequestered in the cytosol through binding to 14-3-3 pro- MOB1A, a highly conserved scaffold protein of the Hippo path- teins or targeted for proteolytic degradation (6, 8). Consequently, way. Here, we show that MOB1A, in addition to being a substrate the main outcome of signal transduction along the Hippo pathway of LegK7, also functions as an allosteric activator of its kinase is changes in gene expression (6).
    [Show full text]
  • Structural Basis for Autoinhibition and Its Relief of MOB1 in the Hippo
    www.nature.com/scientificreports OPEN Structural basis for autoinhibition and its relief of MOB1 in the Hippo pathway Received: 10 February 2016 Sun-Yong Kim, Yuka Tachioka, Tomoyuki Mori & Toshio Hakoshima Accepted: 03 June 2016 MOB1 protein is a key regulator of large tumor suppressor 1/2 (LATS1/2) kinases in the Hippo pathway. Published: 23 June 2016 MOB1 is present in an autoinhibited form and is activated by MST1/2-mediated phosphorylation, although the precise mechanisms responsible for autoinhibition and activation are unknown due to lack of an autoinhibited MOB1 structure. Here, we report on the crystal structure of full-length MOB1B in the autoinhibited form and a complex between the MOB1B core domain and the N-terminal regulation (NTR) domain of LATS1. The structure of full-length MOB1B shows that the N-terminal extension forms a short β-strand, the SN strand, followed by a long conformationally flexible positively-charged linker and α-helix, the Switch helix, which blocks the LATS1 binding surface of MOB1B. The Switch helix is stabilized by β-sheet formation of the SN strand with the S2 strand of the MOB1 core domain. Phosphorylation of Thr12 and Thr35 residues structurally accelerates dissociation of the Switch helix from the LATS1-binding surface by the “pull-the-string” mechanism, thereby enabling LATS1 binding. The Hippo pathway is a key signaling cascade that ensures organ size and normal tissue growth by coordinating cell proliferation and differentiation, and has now been recognized as an essential tumor suppressor cascade1–6. In mammals, the core pathway components comprise two Ser/Thr protein kinases, mammalian Ste20-like 1 and 2 (MST1/2) kinases, members of the Ste20 group in the germinal center kinase II (GCK-II) subgroup, and large tumor suppressor 1 and 2 (LATS1/2) kinases, members of the AGC protein kinase family, in addition to transcriptional co-activator Yes-associated protein (YAP) and transcriptional co-activator with PDZ-binding motif (TAZ).
    [Show full text]
  • Type I and II Interferon Are Associated with High Expression of the Hippo Pathway Family Members
    Cel al & lul ic ar in I l m C m f o u n l a o l n o Journal of Clinical & Cellular r g u y o J ISSN: 2155-9899 Immunology Research Article Type I and II Interferon are Associated with High Expression of the Hippo Pathway Family Members Bianca Sciescia1*, Raquel Tognon2, Natalia de Souza Nunes1, Tathiane Maistro Malta1, Fabiani Gai Frantz1, Fabiola Attie de Castro1, Maira da Costa Cacemiro1 1Department of Clinical, Toxicological and Bromatological Analysis, University of Sao Paulo - USP, Ribeirao Preto - SP, Brazil; 2Department of Pharmacy, Federal University of Juiz de Fora, Campus Governador Valadares, Governador Valadares - MG, Brazil ABSTRACT The Hippo pathway plays a regulatory role on inflammation and cell death and proliferation. Here we described a relationship between Hippo pathway components and inflammation in healthy subjects. The plasma levels of cytokines and chemokines were used to define their inflammatory profile and classify them as normal, high and low producers of cytokines. Leukocytes from healthy subjects with inflammatory profile expressed the highest levels of MSTS1/MST2, SAV1, LATS1/LATS2, MOB1A/MOB1B and YAP genes. The group that overexpressed Hippo pathway-related genes secreted more IFN-ϒ and IFN-α2. Keywords: Hippo pathway; Inflammatory process; Healthy subjects; Cytokines; Chemokines ABBREVATIONS: LATS1/LATS2 kinases (large tumor suppressor kinase 1/2) and MOB kinase activator IL: Interleukin; IFN: Interferon; LATS1/LATS2: Large tumor their adapter proteins MOB1A/MOB1B ( 1A/1B yes-associated suppressor kinase 1/2; MCP-1: Monocyte chemoattractant ), and the transcription coactivators YAP ( protein tafazzin protein protein-1; MIP: Macrophage inflammatory protein; MOB1A/ ) and TAZ ( ).
    [Show full text]
  • The Hippo Signaling Pathway in Drug Resistance in Cancer
    cancers Review The Hippo Signaling Pathway in Drug Resistance in Cancer Renya Zeng and Jixin Dong * Eppley Institute for Research in Cancer and Allied Diseases, Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE 68198, USA; [email protected] * Correspondence: [email protected]; Tel.: +1-402-559-5596; Fax: +1-402-559-4651 Simple Summary: Although great breakthroughs have been made in cancer treatment following the development of targeted therapy and immune therapy, resistance against anti-cancer drugs remains one of the most challenging conundrums. Considerable effort has been made to discover the underlying mechanisms through which malignant tumor cells acquire or develop resistance to anti-cancer treatment. The Hippo signaling pathway appears to play an important role in this process. This review focuses on how components in the human Hippo signaling pathway contribute to drug resistance in a variety of cancer types. This article also summarizes current pharmacological interventions that are able to target the Hippo signaling pathway and serve as potential anti-cancer therapeutics. Abstract: Chemotherapy represents one of the most efficacious strategies to treat cancer patients, bringing advantageous changes at least temporarily even to those patients with incurable malignan- cies. However, most patients respond poorly after a certain number of cycles of treatment due to the development of drug resistance. Resistance to drugs administrated to cancer patients greatly limits the benefits that patients can achieve and continues to be a severe clinical difficulty. Among the mechanisms which have been uncovered to mediate anti-cancer drug resistance, the Hippo signaling pathway is gaining increasing attention due to the remarkable oncogenic activities of its components (for example, YAP and TAZ) and their druggable properties.
    [Show full text]
  • A Study of Alterations in DNA Epigenetic Modifications (5Mc and 5Hmc) and Gene Expression Influenced by Simulated Microgravity I
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Digital Repository @ Iowa State University Genome Informatics Facility Publications Genome Informatics Facility 1-28-2016 A Study of Alterations in DNA Epigenetic Modifications (5mC and 5hmC) and Gene Expression Influenced by Simulated Microgravity in Human Lymphoblastoid Cells Basudev Chowdhury Purdue University Arun S. Seetharam Iowa State University, [email protected] Zhiping Wang Indiana University School of Medicine Yunlong Liu Indiana University School of Medicine Amy C. Lossie Purdue University See next page for additional authors Follow this and additional works at: https://lib.dr.iastate.edu/genomeinformatics_pubs Part of the Bioinformatics Commons, Genetics Commons, and the Genomics Commons Recommended Citation Chowdhury, Basudev; Seetharam, Arun S.; Wang, Zhiping; Liu, Yunlong; Lossie, Amy C.; Thimmapuram, Jyothi; and Irudayaraj, Joseph, "A Study of Alterations in DNA Epigenetic Modifications (5mC and 5hmC) and Gene Expression Influenced by Simulated Microgravity in Human Lymphoblastoid Cells" (2016). Genome Informatics Facility Publications. 4. https://lib.dr.iastate.edu/genomeinformatics_pubs/4 This Article is brought to you for free and open access by the Genome Informatics Facility at Iowa State University Digital Repository. It has been accepted for inclusion in Genome Informatics Facility Publications by an authorized administrator of Iowa State University Digital Repository. For more information, please contact [email protected]. A Study of Alterations in DNA Epigenetic Modifications (5mC and 5hmC) and Gene Expression Influenced by Simulated Microgravity in Human Lymphoblastoid Cells Abstract Cells alter their gene expression in response to exposure to various environmental changes. Epigenetic mechanisms such as DNA methylation are believed to regulate the alterations in gene expression patterns.
    [Show full text]
  • Src Inhibits the Hippo Tumor Suppressor Pathway Through
    Published OnlineFirst July 28, 2017; DOI: 10.1158/0008-5472.CAN-17-0391 Cancer Molecular and Cellular Pathobiology Research Src Inhibits the Hippo Tumor Suppressor Pathway through Tyrosine Phosphorylation of Lats1 Yuan Si1, Xinyan Ji1, Xiaolei Cao1, Xiaoming Dai1, Lingyi Xu1, Hongxia Zhao1, Xiaocan Guo1, Huan Yan1, Haitao Zhang1, Chu Zhu1, Qi Zhou1, Mei Tang1, Zongping Xia1,LiLi2, Yu-Sheng Cong2, Sheng Ye1, Tingbo Liang3, Xin-Hua Feng1, and Bin Zhao1,2 Abstract The Hippo pathway regulates cell proliferation, apoptosis, and Cell matrix adhesion activated the Hippo pathway effector tran- stem cell self-renewal, and its inactivation in animal models scription coactivator YAP partially through Src-mediated phos- causes organ enlargement followed by tumorigenesis. Hippo phorylation and inhibition of LATS1. Aberrant Src activation pathway deregulation occurs in many human cancers, but the abolished the tumor suppressor activity of LATS1 and induced underlying mechanisms are not fully understood. Here, we tumorigenesis in a YAP-dependent manner. Protein levels of Src in report tyrosine phosphorylation of the Hippo pathway tumor human breast cancer tissues correlated with accumulation of suppressor LATS1 as a mechanism underlying its regulation by cell active YAP dephosphorylated on the LATS1 target site. These adhesion. A tyrosine kinase library screen identified Src as the findings reveal tyrosine phosphorylation of LATS1 by Src as a kinase to directly phosphorylate LATS1 on multiple residues, novel mechanism of Hippo pathway regulation by cell adhesion causing attenuated Mob kinase activator binding and structural and suggest Src activation as an underlying reason for YAP dereg- alteration of the substrate-binding pocket in the kinase domain.
    [Show full text]
  • Molecular Insights Into NF2/Merlin Tumor Suppressor Function ⇑ ⇑ Jonathan Cooper , Filippo G
    FEBS Letters 588 (2014) 2743–2752 journal homepage: www.FEBSLetters.org Review Molecular insights into NF2/Merlin tumor suppressor function ⇑ ⇑ Jonathan Cooper , Filippo G. Giancotti Cell Biology Program, Sloan Kettering Institute for Cancer Research, Memorial Sloan Kettering Cancer Center, New York, NY, United States article info abstract Article history: The FERM domain protein Merlin, encoded by the NF2 tumor suppressor gene, regulates cell prolif- Received 26 February 2014 eration in response to adhesive signaling. The growth inhibitory function of Merlin is induced by Revised 1 April 2014 intercellular adhesion and inactivated by joint integrin/receptor tyrosine kinase signaling. Merlin Accepted 2 April 2014 contributes to the formation of cell junctions in polarized tissues, activates anti-mitogenic signaling Available online 12 April 2014 at tight-junctions, and inhibits oncogenic gene expression. Thus, inactivation of Merlin causes Edited by Shairaz Baksh, Giovanni Blandino uncontrolled mitogenic signaling and tumorigenesis. Merlin’s predominant tumor suppressive and Wilhelm Just functions are attributable to its control of oncogenic gene expression through regulation of Hippo signaling. Notably, Merlin translocates to the nucleus where it directly inhibits the CRL4DCAF1 E3 Keywords: ubiquitin ligase, thereby suppressing inhibition of the Lats kinases. A dichotomy in NF2 function Merlin has emerged whereby Merlin acts at the cell cortex to organize cell junctions and propagate anti- Neurofibromatosis Type 2 mitogenic signaling, whereas it inhibits oncogenic gene expression through the inhibition of Hippo signaling pathway CRL4DCAF1 and activation of Hippo signaling. The biochemical events underlying Merlin’s normal Contact inhibition function and tumor suppressive activity will be discussed in this Review, with emphasis on recent DDB1 and Cul4-Associated Factor 1 discoveries that have greatly influenced our understanding of Merlin biology.
    [Show full text]
  • 6372367793149710041845490.Pdf
    ARTICLE DOI: 10.1038/s41467-017-00795-y OPEN Stable MOB1 interaction with Hippo/MST is not essential for development and tissue growth control Yavuz Kulaberoglu 1,6, Kui Lin2, Maxine Holder3, Zhongchao Gai2, Marta Gomez1, Belul Assefa Shifa1, Merdiye Mavis1, Lily Hoa1, Ahmad A.D. Sharif1, Celia Lujan4, Ewan St. John Smith 5, Ivana Bjedov4, Nicolas Tapon3, Geng Wu2 & Alexander Hergovich1 The Hippo tumor suppressor pathway is essential for development and tissue growth control, encompassing a core cassette consisting of the Hippo (MST1/2), Warts (LATS1/2), and Tricornered (NDR1/2) kinases together with MOB1 as an important signaling adaptor. However, it remains unclear which regulatory interactions between MOB1 and the different Hippo core kinases coordinate development, tissue growth, and tumor suppression. Here, we report the crystal structure of the MOB1/NDR2 complex and define key MOB1 residues mediating MOB1’s differential binding to Hippo core kinases, thereby establishing MOB1 variants with selective loss-of-interaction. By studying these variants in human cancer cells and Drosophila, we uncovered that MOB1/Warts binding is essential for tumor suppression, tissue growth control, and development, while stable MOB1/Hippo binding is dispensable and MOB1/Trc binding alone is insufficient. Collectively, we decrypt molecularly, cell biologically, and genetically the importance of the diverse interactions of Hippo core kinases with the pivotal MOB1 signal transducer. 1 Tumour Suppressor Signalling Network Laboratory, UCL Cancer Institute, University College London, London WC1E 6BT, UK. 2 State Key Laboratory of Microbial Metabolism, School of Life Sciences & Biotechnology, Shanghai Jiao Tong University, Shanghai 200240, China. 3 Apoptosis and Proliferation Control Laboratory, Francis Crick Institute, London NW1 1BF, UK.
    [Show full text]
  • Qt8b18n6c6 Nosplash Caf9e24
    Copyright 2014 by Christopher K. Fuller ii For Kai and Lena iii Acknowledgements This work would not have been possible without the support of my research advisor Hao Li. His broad base of interests gave me the freedom to search for something that so well matches my inclinations. I appreciate his insight, enthusiasm, skepticism, and overall encouragement of this effort. I wish to thank my committee, Saunak Sen and Kathleen Giacomini, for their suggestions and support. I wish to thank postdoctoral scholar Xin He for catalyzing the research that became the focus of my work. In addition, I wish to thank postdoctoral scholar Jiashun Zheng for his numerous suggestions and support. I wish to thank the thousands of anonymous individuals who make integrative genomics research possible by providing samples and the researchers dedicated to making these widely available. In addition, I wish to thank the MuTHER and DIAGRAM consortia for providing access to their full summary results. I wish to thank my wife, Sharoni, for her support and for permitting me to encroach on her domain of expertise. You are still the real biologist in the family. Finally, I wish to thank my Mom and Dad ... who took me to the library. iv Abstract Genome-wide association studies (GWAS) have linked various complex diseases to many dozens, sometimes hundreds, of individual genomic loci. Since these are generally of small effect and may lack both functional annotations and an obvious relation to other disease-associated regions, they are difficult to place in a functional context that advances our understanding of the disease.
    [Show full text]
  • Zebrafish Mutants and TEAD Reporters Reveal Essential Functions for Yap
    www.nature.com/scientificreports OPEN Zebrafsh mutants and TEAD reporters reveal essential functions for Yap and Taz in posterior cardinal Received: 15 January 2018 Accepted: 5 June 2018 vein development Published: xx xx xxxx Matteo Astone 1, Jason Kuan Han Lai2, Sirio Dupont 3, Didier Y. R. Stainier2, Francesco Argenton1 & Andrea Vettori 1 As efectors of the Hippo signaling cascade, YAP1 and TAZ are transcriptional regulators playing important roles in development, tissue homeostasis and cancer. A number of diferent cues, including mechanotransduction of extracellular stimuli, adhesion molecules, oncogenic signaling and metabolism modulate YAP1/TAZ nucleo-cytoplasmic shuttling. In the nucleus, YAP1/TAZ tether with the DNA binding proteins TEADs, to activate the expression of target genes that regulate proliferation, migration, cell plasticity, and cell fate. Based on responsive elements present in the human and zebrafsh promoters of the YAP1/TAZ target gene CTGF, we established zebrafsh fuorescent transgenic reporter lines of Yap1/Taz activity. These reporter lines provide an in vivo view of Yap1/Taz activity during development and adulthood at the whole organism level. Transgene expression was detected in many larval tissues including the otic vesicles, heart, pharyngeal arches, muscles and brain and is prominent in endothelial cells. Analysis of vascular development in yap1/taz zebrafsh mutants revealed specifc defects in posterior cardinal vein (PCV) formation, with altered expression of arterial/venous markers. The overactivation
    [Show full text]
  • The Legionella Kinase Legk7 Exploits the Hippo Pathway Scaffold Protein MOB1A for Allostery and Substrate Phosphorylation
    The Legionella kinase LegK7 exploits the Hippo pathway scaffold protein MOB1A for allostery and substrate phosphorylation Pei-Chung Leea,b,1, Ksenia Beyrakhovac,1, Caishuang Xuc, Michal T. Bonieckic, Mitchell H. Leea, Chisom J. Onub, Andrey M. Grishinc, Matthias P. Machnera,2, and Miroslaw Cyglerc,2 aDivision of Molecular and Cellular Biology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, Bethesda, MD 20892; bDepartment of Biological Sciences, College of Liberal Arts and Sciences, Wayne State University, Detroit, MI 48202; and cDepartment of Biochemistry, University of Saskatchewan, Saskatoon, SK S7N5E5, Canada Edited by Ralph R. Isberg, Tufts University School of Medicine, Boston, MA, and approved May 1, 2020 (received for review January 12, 2020) During infection, the bacterial pathogen Legionella pneumophila Active LATS1/2 phosphorylate the cotranscriptional regulator manipulates a variety of host cell signaling pathways, including YAP1 (yes-associated protein 1) and its homolog TAZ (tran- the Hippo pathway which controls cell proliferation and differen- scriptional coactivator with PDZ-binding motif). Phosphorylated tiation in eukaryotes. Our previous studies revealed that L. pneu- YAP1 and TAZ are prevented from entering the nucleus by being mophila encodes the effector kinase LegK7 which phosphorylates either sequestered in the cytosol through binding to 14-3-3 pro- MOB1A, a highly conserved scaffold protein of the Hippo path- teins or targeted for proteolytic degradation (6, 8). Consequently, way. Here, we show that MOB1A, in addition to being a substrate the main outcome of signal transduction along the Hippo pathway of LegK7, also functions as an allosteric activator of its kinase is changes in gene expression (6).
    [Show full text]